Entering text into the input field will update the search result below

Intercept Pharma announces CFO change

Jun. 09, 2016 6:21 PM ETIntercept Pharmaceuticals, Inc. (ICPT) StockBy: Eric Jhonsa, SA News Editor6 Comments
  • Barbara Duncan, Intercept Pharma's (NASDAQ:ICPT) CFO since 2009, is stepping down. Sandip Kapadia, CFO of Novartis' Sandoz generic drug unit, will succeed her, effective July 1.
  • CEO Mark Pruzanski: "Sandip has substantial international financial management experience in the pharmaceutical industry and I look forward to working closely with him as we expand our commercial presence across the world, while advancing our global development programs."

Recommended For You

Related Stocks

SymbolLast Price% Chg
ICPT--
Intercept Pharmaceuticals, Inc.